Is GNOM a good stock to own? Find out who bought Complete Genomics, who sold Complete Genomics (GNOM) stock, and who holds a large position in Complete Genomics.

• Essex Woodlands Health Ventures owns 4.45M shares worth $13.84M
• AQR Capital Management owns 2.44M shares worth $7.68M
• David W. Seeley owns 1.47M shares worth $4.64M
• OrbiMed Advisors owns 1.30M shares worth $4.04M
• Vanguard owns 1.02M shares worth $3.24M
• Oxford Asset Management owns 750889 shares worth $2.37M
• Highland Capital Management owns 640578 shares worth $1.79M
• Cortina Asset Management owns 551542 shares worth $1.56M
• Loeb Offshore Management owns 445732 shares worth $1.40M
• Wolverine Asset Management owns 382935 shares worth $1.19M
• Green Arrow Capital Management owns 375000 shares worth $1.18M
• Technical Financial Services owns 365160 shares worth $1.07M
• Soundpost Partners owns 350000 shares worth $1.08M
• Gabelli Funds owns 324600 shares worth $1.02M
• Private Wealth Partners owns 260100 shares worth $1.53M
• Diamondback Capital Management owns 245140 shares worth $762385
• Frank Russell Company owns 196269 shares worth $612359
• Independence Capital Asset Partners owns 173470 shares worth $1.57M
• STATE STREET CORPORATION owns 155494 shares worth $438493
• 1798 Global Partners owns 146916 shares worth $430463
• Platinum Investment Mangement owns 140000 shares worth $260400
• D. E. Shaw & Co owns 136433 shares worth $253765
• Prescott Group Capital Management owns 118493 shares worth $347184
• Verition Fund Management owns 117000 shares worth $368550
• GOLDMAN SACHS owns 110918 shares worth $312788
• Airain owns 100000 shares worth $315000
• Gilder, Gagnon, Howe & Co owns 96600 shares worth $304290
• Geode Capital Management owns 90872 shares worth $286246
• Veritable owns 86389 shares worth $253119
• Millennium Management owns 85547 shares worth $268617
• WEISS MULTI-STRATEGY ADVISERS owns 85000 shares worth $249050
• WEISS MULTI-STRATEGY ADVISERS owns 85000 shares worth $249050
• Wentworth, Hauser & Violich owns 74005 shares worth $233115
• FIRST NEW YORK SECURITIES owns 71600 shares worth $221244
• TIAA-CREF Investment Management owns 66976 shares worth $188872
• Gabelli Securities owns 63846 shares worth $201114
• Harvest Management owns 63800 shares worth $200970
• Renaissance Technologies owns 63478 shares worth $199955
• CalPERS owns 61500 shares worth $193725
• Bascom Hill Partners owns 60001 shares worth $169202
• ALLIANCEBERNSTEIN owns 54164 shares worth $100745
• Visium Asset Management owns 50000 shares worth $158000
• Ascend Capital owns 45870 shares worth $141738
• CNH Partners owns 45012 shares worth $139987
• UBS AG owns 42470 shares worth $133355
• Parametric Portfolio Associates owns 39971 shares worth $123910
• Nomura Holdings owns 39769 shares worth $123283

• Frontier Capital Management sold on Sept. 30, 2011
• Pier Capital sold on Sept. 30, 2011
• Cupps Capital Management sold on Sept. 30, 2011
• Wells Fargo & Company sold on Sept. 30, 2011
• Magnetar Financial sold on Sept. 30, 2011
• Thomas Weisel Asset Management sold on Sept. 30, 2011
• Edgewood Management sold on Sept. 30, 2011
• Citi sold on Sept. 30, 2011
• Driehaus Capital Management sold on June 30, 2011
• Copper Rock Capital Partners sold on June 30, 2011
• Eudaimonia Asset Management sold on June 30, 2011
• Allianz Global Investors of America sold on June 30, 2011
• Tudor Investment Corporation sold on June 30, 2011
• AH Lisanti Capital Growth sold on June 30, 2011
• Credit Suisse AG sold on June 30, 2011
• CITADEL ADVISORS sold on June 30, 2011
• Independence Capital Asset Partners sold on March 31, 2011
• Levin Capital Strategies sold on March 31, 2011
• Austin W. Marxe and David M. Greenhouse sold on Dec. 31, 2010
• Jennison Associates sold on Dec. 31, 2010

• Abbott Laboratories (ABT)
• Baxter International (BAX)
• BioMarin Pharmaceutical (BMRN)
• Incyte Corporation (INCY)
• Eli Lilly & Co. (LLY)
• MAP Pharmaceuticals (MAPP)
• Pfizer (PFE)
• Regeneron Pharmaceuticals (REGN)
• Cardinal Health (CAH)
• Bristol Myers Squibb (BMY)
• Edwards Lifesciences (EW)
• Hologic (HOLX)
• Boston Scientific Corporation (BSX)
• Medtronic (MDT)
• Affymetrix (AFFX)
• DaVita (DVA)
• Thermo Fisher Scientific (TMO)
• Aetna (AET)
• Merck & Co (MRK)
• Solta Medical (SLTM)
• Complete Genomics (GNOM)